Zoetis introduces Core EQ Innovator

Zoetis, Parsippany, New Jersey, has introduced Core EQ Innovator, the first and only equine vaccine to contain all five core equine disease antigens—West Nile, Eastern and Western Equine encephalomyelitis, tetanus and rabies—in one smooth vaccine. As defined by the American Association of Equine Practitioners and the American Veterinary Medical Association, these diseases are designated as core because all horses are at risk for exposure, all have a high fatality rate, and some may present a potential human health risk. Annual vaccination is the only way to help protect horses from the deadly core equine diseases. Core EQ Innovator is available only through veterinarians to provide additional assurance horses are vaccinated properly. Core EQ Innovator provides a safe and effective immune response against the five core equine disease antigens as demonstrated in safety and efficacy trials. The vaccine has been field tested in more than 1,000 horses with 99.7 percent of horses being reaction-free. With a convenient 1-mL dose size, the vaccine is safe for use in healthy horses 3 months of age or older. For more information, see a representative or visit www.CoreEQInnovator.com.